{"log_id": 8336230464795924147, "direction": 0, "words_result_num": 33, "words_result": [{"probability": {"variance": 0.012141, "average": 0.953167, "min": 0.488347}, "location": {"width": 919, "top": 156, "height": 43, "left": 172}, "words": "口服避孕药,利福平,苯巴比妥和卡马西平,噻嗪类药物,皮质激素,达那唑,甲状腺激素,奥曲肽"}, {"probability": {"variance": 0.016524, "average": 0.941921, "min": 0.627462}, "location": {"width": 145, "top": 208, "height": 22, "left": 131}, "words": "和拟交感神经药"}, {"probability": {"variance": 0.001923, "average": 0.982394, "min": 0.732032}, "location": {"width": 923, "top": 250, "height": 43, "left": 166}, "words": "β受体阻滞剂会掩盖低血糖症状。当接受瑞格列奈治疗的患者使用或停止使用这些药物时,应密切监测"}, {"probability": {"variance": 2.4e-05, "average": 0.995808, "min": 0.987698}, "location": {"width": 143, "top": 300, "height": 26, "left": 128}, "words": "患者血糖的变化"}, {"probability": {"variance": 0.000824, "average": 0.985396, "min": 0.92127}, "location": {"width": 112, "top": 346, "height": 24, "left": 132}, "words": "【药物过量】"}, {"probability": {"variance": 0.00187, "average": 0.985345, "min": 0.790241}, "location": {"width": 895, "top": 392, "height": 39, "left": 187}, "words": "项在2型糖尿病患者中开展的临床试验中,每周增加瑞格列奈的服药量,在超过6周的时间范围内"}, {"probability": {"variance": 0.025661, "average": 0.935584, "min": 0.350587}, "location": {"width": 960, "top": 438, "height": 39, "left": 123}, "words": "服药量从4i增加至20mg患者每日次在进餐时服药。除与血糖降低相关的可预期的影响外,基本未出"}, {"probability": {"variance": 0.009719, "average": 0.960121, "min": 0.530034}, "location": {"width": 958, "top": 483, "height": 42, "left": 122}, "words": "现不良事件,由于该研究中通过增加热量摄取的方法以减少低血糖症状的发生,因此药物相对过最公可能"}, {"probability": {"variance": 0.002094, "average": 0.989194, "min": 0.708828}, "location": {"width": 958, "top": 531, "height": 39, "left": 122}, "words": "表现为降糖作用的增大及出现低血糖症状(头晕、出汗、震颤、头痛等)。一出现这些反应,应采取有效"}, {"probability": {"variance": 0.004874, "average": 0.972604, "min": 0.57137}, "location": {"width": 962, "top": 577, "height": 41, "left": 116}, "words": "措施纠正低血糖(口服碳水化合物)。更严重的低血糖伴有癫痫、意识丧失和昏迷,这种情况下,应静脉输"}, {"probability": {"variance": 0.033176, "average": 0.834178, "min": 0.52299}, "location": {"width": 82, "top": 625, "height": 24, "left": 118}, "words": "入前萄糖"}, {"probability": {"variance": 0.000773, "average": 0.978319, "min": 0.934871}, "location": {"width": 110, "top": 673, "height": 23, "left": 124}, "words": "【药理毒理】"}, {"probability": {"variance": 0.000564, "average": 0.989141, "min": 0.894816}, "location": {"width": 922, "top": 717, "height": 42, "left": 157}, "words": "本品为短效口服降血糖药,通过促进胰腺β细胞的胰岛素分泌,降低血糖水平。其作用机理是通过与β"}, {"probability": {"variance": 0.006491, "average": 0.968032, "min": 0.582868}, "location": {"width": 961, "top": 764, "height": 42, "left": 113}, "words": "孢膜上的特定位点结合,关闭细胞膜上ATP依赖性钾通道,使β细胞去极化,导致其钙通道开放,钙的"}, {"probability": {"variance": 0.010755, "average": 0.945086, "min": 0.601779}, "location": {"width": 288, "top": 815, "height": 26, "left": 117}, "words": "内流增加,从而促使胰岛素分泌"}, {"probability": {"variance": 2.8e-05, "average": 0.996464, "min": 0.983926}, "location": {"width": 135, "top": 860, "height": 26, "left": 117}, "words": "【药代动力学】"}, {"probability": {"variance": 0.016711, "average": 0.941315, "min": 0.399629}, "location": {"width": 919, "top": 906, "height": 42, "left": 151}, "words": "瑞格列奈经胃肠道快速吸收、导致谊浆药物浓度迅速升高。服药后1小时内浆药物浓度达峰值。然"}, {"probability": {"variance": 0.008263, "average": 0.972002, "min": 0.414215}, "location": {"width": 952, "top": 953, "height": 42, "left": 109}, "words": "后血浆浓度迅速下降,4~6小时内被清除。血浆半衰期约为1小时。瑞格列与人血浆蛋白的结合大于98%"}, {"probability": {"variance": 0.006615, "average": 0.968019, "min": 0.578117}, "location": {"width": 954, "top": 1000, "height": 41, "left": 108}, "words": "瑞格列奈儿乎全部被代谢,代谢物未见有任何临床意义的降血糖作用。瑞格列奈及其代谢产物主要白胆汁"}, {"probability": {"variance": 0.003872, "average": 0.977051, "min": 0.724544}, "location": {"width": 691, "top": 1048, "height": 37, "left": 105}, "words": "银泄,很小部分(小于8%)代谢产物白尿排出。粪便中的原形药物少于2%"}, {"probability": {"variance": 0.003452, "average": 0.972388, "min": 0.753688}, "location": {"width": 426, "top": 1097, "height": 28, "left": 144}, "words": "据国外文献报道,对肾功能正常(CrCl>80mL/m"}, {"probability": {"variance": 0.005917, "average": 0.960037, "min": 0.680872}, "location": {"width": 439, "top": 1102, "height": 35, "left": 615}, "words": "伴有轻微和中度肾功能损伤(CrCl=40~80mL/min"}, {"probability": {"variance": 0.003015, "average": 0.972029, "min": 0.805795}, "location": {"width": 284, "top": 1145, "height": 25, "left": 105}, "words": "和严重肾功能损伤(CrCl=20~40"}, {"probability": {"variance": 0.000623, "average": 0.989078, "min": 0.886281}, "location": {"width": 614, "top": 1147, "height": 37, "left": 443}, "words": "n)的2型糖尿病患者给予单剂量瑞格列奈后的稳态药动学做了比较"}, {"probability": {"variance": 0.004106, "average": 0.972083, "min": 0.682328}, "location": {"width": 956, "top": 1190, "height": 42, "left": 103}, "words": "肾功能正常的患者与伴有轻微和中度肾功能损伤的患者问的AUC和 I Cmas相似(平均值分别为56.7ng/mLh"}, {"probability": {"variance": 0.01161, "average": 0.945172, "min": 0.447342}, "location": {"width": 962, "top": 1238, "height": 41, "left": 100}, "words": "和57.2ng/mL*hr:37.5ng/mL和37.7g/mL),伴有严重肾功能损伤的患者的AUC和Cmax均大幅增加(分别"}, {"probability": {"variance": 0.013119, "average": 0.946037, "min": 0.38947}, "location": {"width": 961, "top": 1285, "height": 41, "left": 100}, "words": "为98.0ng/mLhr和50.7ng/mL),但是这项研究仅仅表明瑞格列奈浓度与肌酐清除率(CrC1)之间存在微弱"}, {"probability": {"variance": 0.007988, "average": 0.977528, "min": 0.410573}, "location": {"width": 961, "top": 1332, "height": 41, "left": 96}, "words": "的关联伴有轻微和中度肾功能损伤的患者无需调整起始剂量。然而,伴有严重肾功能损伤的2型糖尿病"}, {"probability": {"variance": 0.002897, "average": 0.985747, "min": 0.619151}, "location": {"width": 960, "top": 1380, "height": 42, "left": 96}, "words": "患者的起始剂量应定为0.5mg,然后再谨慎地调整剂量。在肌酐清除率低于20mL/min以及需要血液透析"}, {"probability": {"variance": 2e-05, "average": 0.997213, "min": 0.984005}, "location": {"width": 294, "top": 1430, "height": 27, "left": 95}, "words": "的肾衰患者中的研究尚未开展过"}, {"probability": {"variance": 0, "average": 0.955847, "min": 0.955847}, "location": {"width": 27, "top": 1436, "height": 32, "left": 1046}, "words": "3"}, {"probability": {"variance": 0.016469, "average": 0.936407, "min": 0.384129}, "location": {"width": 932, "top": 1479, "height": 38, "left": 135}, "words": "据国外文献报道,在12名健康受试者和12名按照 child-pugh分级和咖啡因清除率分级的慢性病息"}, {"probability": {"variance": 0.007046, "average": 0.962695, "min": 0.53248}, "location": {"width": 960, "top": 1524, "height": 41, "left": 95}, "words": "者中展开了一项单剂量、标签公开的研究。与健康受试者相比,伴有中度全重度肝功能损伤的患者的瑞格"}], "language": 3}